1. Home
  2. QRTEA vs RIGL Comparison

QRTEA vs RIGL Comparison

Compare QRTEA & RIGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QRTEA
  • RIGL
  • Stock Information
  • Founded
  • QRTEA 1991
  • RIGL 1996
  • Country
  • QRTEA United States
  • RIGL United States
  • Employees
  • QRTEA N/A
  • RIGL N/A
  • Industry
  • QRTEA Catalog/Specialty Distribution
  • RIGL Biotechnology: Pharmaceutical Preparations
  • Sector
  • QRTEA Consumer Discretionary
  • RIGL Health Care
  • Exchange
  • QRTEA Nasdaq
  • RIGL Nasdaq
  • Market Cap
  • QRTEA 239.9M
  • RIGL 282.2M
  • IPO Year
  • QRTEA N/A
  • RIGL 2000
  • Fundamental
  • Price
  • QRTEA $0.59
  • RIGL $15.18
  • Analyst Decision
  • QRTEA
  • RIGL Buy
  • Analyst Count
  • QRTEA 0
  • RIGL 4
  • Target Price
  • QRTEA N/A
  • RIGL $31.13
  • AVG Volume (30 Days)
  • QRTEA 3.3M
  • RIGL 224.7K
  • Earning Date
  • QRTEA 11-07-2024
  • RIGL 11-05-2024
  • Dividend Yield
  • QRTEA N/A
  • RIGL N/A
  • EPS Growth
  • QRTEA N/A
  • RIGL N/A
  • EPS
  • QRTEA N/A
  • RIGL N/A
  • Revenue
  • QRTEA $10,371,000,000.00
  • RIGL $130,201,000.00
  • Revenue This Year
  • QRTEA N/A
  • RIGL $38.26
  • Revenue Next Year
  • QRTEA N/A
  • RIGL $24.21
  • P/E Ratio
  • QRTEA N/A
  • RIGL N/A
  • Revenue Growth
  • QRTEA N/A
  • RIGL 7.48
  • 52 Week Low
  • QRTEA $0.40
  • RIGL $7.10
  • 52 Week High
  • QRTEA $1.80
  • RIGL $17.30
  • Technical
  • Relative Strength Index (RSI)
  • QRTEA 48.38
  • RIGL 54.30
  • Support Level
  • QRTEA $0.50
  • RIGL $14.87
  • Resistance Level
  • QRTEA $0.65
  • RIGL $16.85
  • Average True Range (ATR)
  • QRTEA 0.05
  • RIGL 0.90
  • MACD
  • QRTEA 0.00
  • RIGL -0.20
  • Stochastic Oscillator
  • QRTEA 42.35
  • RIGL 38.07

About QRTEA Qurate Retail Inc. Series A

Qurate Retail Inc, through its subsidiaries, is engaged in the video and online commerce industries. Its segments include QxH, which includes QVC U.S. and HSN market and sell a wide variety of consumer products in the United States, using their televised shopping programs and via the Internet through their websites and mobile applications; QVC International segment markets and sells a wide variety of consumer products in several foreign countries, using its televised shopping programs and via the Internet through its international websites and mobile applications; and Zulily markets and sells a wide variety of consumer products in the United States and several foreign countries. Geographically, the company operates in U.S, which generates key revenue, Japan, Germany and other regions.

About RIGL Rigel Pharmaceuticals Inc.

Rigel Pharmaceuticals Inc develops small-molecule drugs for autoimmune, cancer-related, and viral diseases. The firm's lead drug is an oral rheumatoid arthritis drug candidate that has been licensed to AstraZeneca. Astra has taken overall responsibility for developing and marketing the drug and will pay Rigel royalties and milestone payments. Its pipeline product includes TAVALISSE (fostamatinib disodium hexahydrate) tablets, the only oral spleen tyrosine kinase (SYK) inhibitor, Fostamatinib, R289, R552, R835, DS-3032, THF-beta Inhibitors, and AZD0449- Inhaled JAK Inhibitor.

Share on Social Networks: